Literature DB >> 9860372

Atherosclerosis and acute coronary events.

S Dalager-Pedersen1, H B Ravn, E Falk.   

Abstract

Without thrombosis, coronary atherosclerosis is generally benign. It is plaque disruption, or fissuring, and subsequent thrombosis that make coronary atherosclerosis dangerous. Small ruptures often remain clinically silent, whereas more extensive plaque rupture may cause the development of unstable angina, myocardial infarction, and sudden death. The risk of plaque disruption depends more on plaque type (composition) than on plaque size and stenosis severity. Both plaque vulnerability (intrinsic disease) and rupture triggers (extrinsic forces) are important for plaque disruption. The resultant thrombotic response, which affects the clinical presentation and outcome, is partly determined by the reactivity of the circulating platelets and the balance between the coagulation and fibrinolytic systems. To prevent and treat life-threatening coronary thrombosis, the medical community should seek new ways to identify and treat dangerous, vulnerable plaques and to optimize antithrombotic treatment.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9860372     DOI: 10.1016/s0002-9149(98)00721-8

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

1.  Cell therapy for myocardial infarction.

Authors:  Yoo-Wook Kwon; Han-Mo Yang; Hyun-Jai Cho
Journal:  Int J Stem Cells       Date:  2010-05       Impact factor: 2.500

2.  Baccaurea angulata fruit inhibits lipid peroxidation and induces the increase in antioxidant enzyme activities.

Authors:  Maryam Abimbola Mikail; Idris Adewale Ahmed; Muhammad Ibrahim; Norazlanshah Hazali; Mohammad Syaiful Bahari Abdul Rasad; Radiah Abdul Ghani; Ridzwan Hashim; Ridhwan Abdul Wahab; Solachuddin Jahuari Arief; Muhammad Lokman Md Isa; Samsul Draman; Mohammad Noor Adros Yahya
Journal:  Eur J Nutr       Date:  2015-06-20       Impact factor: 5.614

Review 3.  Antiplatelet therapy in populations at high risk of atherothrombosis.

Authors:  David P Faxon; Richard W Nesto
Journal:  J Natl Med Assoc       Date:  2006-05       Impact factor: 1.798

4.  A murine model of myocardial microvascular thrombosis.

Authors:  P D Christie; J M Edelberg; M H Picard; A S Foulkes; W Mamuya; H Weiler-Guettler; R H Rubin; P Gilbert; R D Rosenberg
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

5.  Bilirubin ameliorates murine atherosclerosis through inhibiting cholesterol synthesis and reshaping the immune system.

Authors:  Guanmei Wen; Leyi Yao; Yali Hao; Jinheng Wang; Jinbao Liu
Journal:  J Transl Med       Date:  2022-01-03       Impact factor: 5.531

6.  Is the WHI relevant to HRT started in the perimenopause?

Authors:  S Mitchell Harman; Eliot A Brinton; Thomas Clarkson; Christopher B Heward; Harvey S Hecht; Richard H Karas; Debra R Judelson; Frederick Naftolin
Journal:  Endocrine       Date:  2004-08       Impact factor: 3.925

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.